Search
Menu
Home
HTB
2017
November
24
HTB
24 November 2017
Contents
Antiretrovirals
Coformulated dolutegravir plus rilpivirine approved in US (Juluca)
Darunavir-based single pill FDC approved in EU (Symtuza)
HTB RSS
Current issues
April 2024
March 2024
February 2024
Back issues
Special report
Uganda Court rejects appeal against the LGBTQ+ hate law
5 April 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage